Trial intelligence / Profile preview

Effects of Oral Iron Supplementation on Gut Microbiota in CKD

NCT05544513Phase 2Active, not recruiting

Sponsor
Universidade Federal Fluminense
Start
Aug 2022
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ferrous sulfate in iron deficiency anemia (IDA), anemia of chronic kidney disease (CKD-A), sponsored by Universidade Federal Fluminense. Started Aug 2022; status: active, not recruiting.

02

Drugs

ferrous sulfate
03

Conditions

iron deficiency anemia (IDA)anemia of chronic kidney disease (CKD-A)

Beyond the preview

Go deeper on NCT05544513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05544513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call